|1.||Peng, Ling: 2 articles (03/2012 - 08/2009)|
|2.||Rocchi, Palma: 2 articles (03/2012 - 08/2009)|
|3.||Kubis, Aleksander: 2 articles (01/2004 - 03/2003)|
|4.||Musiał, Witold: 2 articles (01/2004 - 03/2003)|
|5.||Gola, Massimo: 1 article (05/2015)|
|6.||Milanesi, Nicola: 1 article (05/2015)|
|7.||Berti, Samantha: 1 article (05/2015)|
|8.||Kirilenko, E A: 1 article (01/2015)|
|9.||Kurashova, N A: 1 article (01/2015)|
|10.||Neronova, N A: 1 article (01/2015)|
06/01/2014 - "The efficacy of Rp group in treating radiation dermatitis was better than the Trolamine cream group by 16.5% (P < 0.05). "
05/01/2006 - "The results of this trial demonstrate no advantage for the use of trolamine in reducing the incidence of grade 2 or higher radiation dermatitis or improving patient-reported QOL. "
04/15/2004 - "The occurrence of acute dermatitis of grade 2 or higher was significantly lower (41% v 63%; P <.001) with the use of calendula than with trolamine. "
04/15/2004 - "Phase III randomized trial of Calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer."
05/01/2006 - "Phase III Trial of an emulsion containing trolamine for the prevention of radiation dermatitis in patients with advanced squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Trial 99-13."
|2.||Head and Neck Neoplasms (Head and Neck Cancer)
05/01/2006 - "This multicentered phase III trial was designed to compare an emulsion containing trolamine against the usual supportive care within each participating institution for patients with head and neck cancer undergoing radiation therapy. "
01/01/2012 - "This phase III trial was designed to test trolamine emulsion compared with the usual supportive care for patients with head and neck cancer undergoing radiation therapy with concurrent chemotherapy. "
01/01/1986 - "These results may indicate that a positive trend in the occurrence of these tumors is not attributable to triethanolamine administration. "
10/01/2008 - "In one of these studies, increased hepatocellular neoplasms at the high doses in male and female mice exposed topically to triethanolamine (TEA) provided the only evidence of carcinogenic activity. "
06/01/2004 - "Triethanolamine (TEA), a widely used nongenotoxic alcohol-amine, has recently been reported to cause an increased incidence of liver tumors in female B6C3F1 mice, but not in males nor in Fischer 344 rats. "
04/01/2006 - "Here we show that a chemical conjugate of the L19 antibody with the photosensitizer bis(triethanolamine)Sn(IV) chlorin e(6), after intravenous injection and irradiation with red light, caused an arrest of tumor growth in mice with subcutaneous tumors. "
01/01/2012 - "Patients with biopsy-proven head and neck squamous cell carcinoma (HNSCC) treated with radical radiotherapy and weekly concurrent cisplatin 40 mg/m(2) at the South Egypt Cancer Institute (Assiut) were randomly assigned to one of the following groups: treatment group (prophylactic trolamine emulsion every 8 h, 4 h apart from the radiotherapy session) or control group (usual supportive care). "
|4.||Prostatic Neoplasms (Prostate Cancer)
03/05/2012 - "Efficient delivery of sticky siRNA and potent gene silencing in a prostate cancer model using a generation 5 triethanolamine-core PAMAM dendrimer."
03/05/2012 - "In the present study, we demonstrate that a triethanolamine (TEA)-core PAMAM dendrimer of generation 5 (G(5)) is able to deliver sticky siRNAs bearing complementary A(n)/T(n) 3'-overhangs effectively to a prostate cancer model in vitro and in vivo and produce potent gene silencing of the heat shock protein 27, leading to a notable anticancer effect. "
08/01/2009 - "Herein we report that structurally flexible triethanolamine (TEA) core PAMAM dendrimers are able to deliver an Hsp27 siRNA effectively into prostate cancer (PC-3) cells by forming stable nanoparticles with siRNA, protecting the siRNA nanoparticles from enzymatic degradation, and enhancing cellular uptake of siRNA. "
01/01/2009 - " studies with low risk of bias demonstrated benefit: one with 254 participants demonstrated superiority of topical calendula over trolamine (a topical agent not containing corticosteroids) for prevention of radiotherapy-induced dermatitis, and another with 32 participants demonstrated superiority of Traumeel S (a proprietary complex homeopathic medicine) over placebo as a mouthwash for chemotherapy-induced stomatitis. "
|2.||squamous cell of head and neck Carcinoma
|3.||HSP27 Heat-Shock Proteins
|4.||Adrenal Cortex Hormones (Corticosteroids)
|8.||Small Interfering RNA (siRNA)
|10.||Polyethylene Glycols (Polyethylene Glycol)
|1.||Drug Therapy (Chemotherapy)